No Data
GSK Target Cut to 1,525p From 2,000p by Jefferies
Jefferies Downgrades GlaxoSmithKline(GSK.US) to Hold Rating, Cuts Target Price to $39.5
GlaxoSmithKline (GSK) Was Downgraded to a Hold Rating at Jefferies
Express News | ViiV Healthcare's DOLCE Study Shows 2-Drug Regimen Dovato Is Highly Effective In Treatment-Naïve People With Advanced HIV, Matching 3-Drug Therapy Efficacy At 48 Weeks
FDA recommends stopping the use of common decongestants in cold medicines, companies like glaxosmithkline (GSK.US) may be affected.
The U.S. Food and Drug Administration (FDA) announced on Thursday that it has proposed to remove oral phenylephrine widely used in cold and cough syrups from the list of active ingredients for over-the-counter medications for nasal congestion, deeming it ineffective.
Barclays Sticks to Their Hold Rating for GlaxoSmithKline (GSK)
No Data
No Data
